Narrow Your Results

Using responses from an online questionnaire, this study characterized the frequency, causes and possible risk factors of operating room fires.

This week, an Instagram model undergoes surgery to change her eye color but instead loses her vision, a miniature scanner captures retinal images in incredible detail and Thomas W. Samuelson, MD, is crowned the new president of ASCRS.

This retrospective study examined whether herpes zoster antigen could be detected in temporal artery biopsies taken from individuals with giant cell arteritis.

This phase 3 extension of the VISUAL trials evaluated the safety and efficacy of adalimumab in patients with noninfectious intermediate, posterior or panuveitis.

Iowa-based biotech firm IDx, LLC has gained regulatory approval for the first artificial intelligence device capable of screening for diabetic retinopathy.

Johnson & Johnson’s light-adaptive contact lenses have been approved by the United States Food and Drug Administration.

This population-based study assessed whether pregnant women taking topiramate during the first trimester had a higher risk of giving birth to infants with oral clefts.

This week, Pope Francis announces plans to undergo cataract surgery, ophthalmologists and optometrists are at odds in Illinois and drug makers ask the Supreme Court to weigh in on allegations that eyedrop bottles inefficiently dispense medication.

Researchers from University of Southern California are the first to show the feasibility of a stem cell-based implant in people with advanced dry AMD, with no adverse events noted through 1 year.

Investigators evaluated the effectiveness of curative and preventative surgical strategies for negative dysphotopsia.

This prospective study describes the incidence and presenting features of congenital dacryocystocele in the United Kingdom.

This retrospective study assessed outcomes and relapse rates among patients with juvenile idiopathic arthritis (JIA)-associated uveitis upon discontinuation of immunomodulatory therapy.

Investigators of this observational study examined topographical changes in patients with keratoconus while awaiting corneal crosslinking (CXL) treatment.

This week, a proprietary technology described as "reverse chocolate" could help treat dry eye, a compound found in broccoli may stave off AMD and a surgeon details his anxiety-laden experience administering a newly approved (and very pricey) gene therapy for the first time.

Genentech announced the approval of a single-use syringe prefilled with 0.3 mg of ranibizumab for treating all forms of diabetic retinopathy (DR), with or without diabetic macular edema (DME).

This retrospective analysis examined risk factors for early graft detachment in Descemet membrane endothelial keratoplasty (DMEK).

This retrospective, multicenter case series examined the long-term visual outcomes of 27-gauge pars plana vitrectomy in patients with posterior segment disease.

This study examines the clinical course of atypical pituitary adenoma with orbital invasion, a rare and aggressive condition that is often refractory to treatment.

Chinese researchers have unveiled a new class of retinal prosthesis that relies on nanotechnology to restore the light response.

This week, researchers describe how the eyes rehearse visual scenes to commit them to memory, a novel eyedrop attracts investors and AMD research is poised for progress with an extraordinary donation and an international study.

AcuFocus will sell the Kamra technology to Seattle-based SightLife Surgical, according to a press release on the company’s website.

Sagent Pharmaceuticals announced a voluntary nationwide recall of 10 lots of methylprednisolone sodium succinate (40mg, 125mg and 1g) due to high impurity levels detected during routine quality testing.

Patients who undergo uncomplicated vitreoretinal surgery can safely be examined on the second postoperative day without negative effects, according to this small study.

This week, Allergan’s high-profile patent fight rages on, Indiana takes a stance against scleral tattoos and a journalist recalls how his life changed in the wake of an “eye stroke” that silently stole his vision during the night.

Novel antithrombotics pose an equal or lower risk of intraocular hemorrhage than their traditional counterparts, according to this analysis of insurance claims.